September is National Blood Cancer Awareness Month
2017 Conference registration is now closed!
The mission of MPN-NET, and Online Forum, is to bring information, education and support to our members
For the Landmark study results click on the Research page
Myeloproliferative neoplasms (MPN) are relatively rare chronic hematologic malignancies that include the classic Myeloproliferative Neoplasm Disorders:
Essential Thrombocythemia (ET)
Polycythemia Vera (PV
Chronic Myelogenous Leukemia (CML)
There are atypical Myeloproliferative Neoplasm Disorders which include molecularly defined PDGFRA-rearranged eosinophilic/mast cell disorders; PDGFRB-rearranged eosinophilic disorders; systemic mastocytosis associated with c-kit mutation; 8p11 Myeloproliferative syndrome; and juvenile myelomonocytic leukemia with recurrent mutations of RAS. MPN also includes the clinicopathologically assigned variants: chronic neutrophilic leukemia; chronic eosinophilic leukemia; hypereosinophillic syndrome, chronic basophilic leukemia, chronic monomyelomonocytic leukemia, systemic mastocytosis; and unclassified myeloproliferative disorder. Chronic myeloid disorders also include myelodysplastic syndrome.
If you or a loved one have been diagnosed with one of these rare disorders,
YOU ARE NOT ALONE, HELP IS JUST A CLICK AWAY.
Scientific Advisory Board:
John Camoriano, MD, Mayo Clinic, Scottsdale, Arizona
Joachim Deeg, MD, Fred Hutchinson Cancer Research Center, Seattle, Washington
Claire Harrison, MD, Guy's and St. Thomas' Hospital, London, UK
Ruben Mesa, MD, Mayo Clinic, Scottsdale, Arizona
Ayalew Tefferi, MD, Mayo Clinic, Rochester, Minnesota
Srdan Verstovsek, MD, MD Anderson Cancer Center, Houston, Texas